Exane Derivatives’s Xtrackers Harvest CSI 300 China A-Shares ETF ASHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-14,028
Closed -$548K 1020
2021
Q4
$548K Hold
14,028
0.13% 162
2021
Q3
$535K Sell
14,028
-5,866
-29% -$226K 0.13% 177
2021
Q2
$795K Buy
19,894
+14,028
+239% +$559K 0.18% 108
2021
Q1
$227K Buy
+5,866
New +$245K 0.06% 282

Other funds holding ASHR

Exane Derivatives's ASHR Position: Q1 2022 in Review

Exane Derivatives sold out of Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) in Q1 2022, closing a stake of 14,028 shares — an estimated $548K sold.

Exane Derivatives first reported a position in ASHR in Q1 2021 and held it in 4 quarters. The position peaked at $795K in Q2 2021. 155 funds tracked by Wall St. Rank hold ASHR as of Q1 2022.

  • Exane Derivatives reported no remaining Xtrackers Harvest CSI 300 China A-Shares ETF position as of Q1 2022 after selling out during the quarter.
  • Exane Derivatives sold 14,028 Xtrackers Harvest CSI 300 China A-Shares ETF shares in Q1 2022, an estimated $548K.
  • Exane Derivatives first reported a position in Xtrackers Harvest CSI 300 China A-Shares ETF in Q1 2021 and held it in 4 quarters.
  • Exane Derivatives's Xtrackers Harvest CSI 300 China A-Shares ETF position peaked at $795K in Q2 2021.
  • 155 funds tracked by Wall St. Rank held Xtrackers Harvest CSI 300 China A-Shares ETF as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.